Financial Disclosure

Dragonfly Energy Lands $3M Stevens Trucking Order, Guides Q2 Up 36%

Image
Dragonfly Energy Lands $3M Stevens Trucking Order, Guides Q2 Up 36%

RENO – October 27, 2026 -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) guided second-quarter net sales to about $13.2 million, roughly 36% above first-quarter revenue of $9.7 million, as a purchase order from Stevens Transport covering nearly 500 trucks offsets a soft RV market.

Stevens Transport order exceeds $3 million across full trucking portfolio

Stevens Transport placed the order after quarter-end. It is valued at more than $3 million and spans Dragonfly's full heavy-duty trucking product portfolio. CEO Denis Phares described it as one of the most comprehensive single-fleet adoptions of the company's trucking solutions to date, and as a move from pilot programs to scaled fleet deployment.

Dragonfly Energy Cuts EBITDA Loss $3.0M in Q2, Buys Dakota Lithium

Image
Dragonfly Energy Cuts EBITDA Loss $3.0M in Q2, Buys Dakota Lithium

RENO – October 27, 2026 -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) narrowed its second-quarter Adjusted EBITDA loss to $1.6 million, a $3.0 million sequential improvement from the first quarter, as cost cuts took hold. Preliminary net sales of $13.2 million matched company guidance, and Adjusted EBITDA came in above it.

Cost cuts lift margins while sales fall

Gross profit was $4.3 million at a 33.0% gross margin, against $4.6 million and 28.3% in the comparison period. Lower battery and accessory unit volumes reduced gross profit, partly offset by a $1.1 million tariff refund booked in cost of sales. Operating expenses fell to $7.2 million from $7.9 million.

Q2 Revenue Climbs 22% to $1.92B as Tariff Receivable Lifts Profit

Image
Q2 Revenue Climbs 22% to $1.92B as Tariff Receivable Lifts Profit

Norwalk, Conn. – October 27, 2026 -- Second-quarter 2026 revenue rose 22.0 percent to $1.92 billion, while adjusted operating margin widened 690 basis points to 10.6 percent. A $105 million pre-tax benefit from recognizing IEEPA tariff receivables contributed to the profit figures.

Reported revenue growth contrasts with a 6.5 percent pro forma decline

Revenue grew 21.2 percent in constant currency. On a pro forma basis, revenue fell 6.5 percent, so the headline increase is not matched by the like-for-like comparison.

Adjusted operating income rises $144 million to $203 million

GAAP net income reached $13 million, or $0.07 per share. That is up $119 million, or $0.94 per share, year-over-year.

Adjusted net income came in at $55 million, or $0.38 per share, up $132 million, or $1.02 per share.

Mobil Krankenkasse Publishes 2025 Business and Transparency Reports

Image
Mobil Krankenkasse Publishes 2025 Business and Transparency Reports

Hamburg – October 27, 2026 -- Mobil Krankenkasse has published its 2025 business report and transparency report, with the Innovation Fund project moVe-it as the central care initiative.

moVe-it targets post-stroke spasticity care through digital case management

The business report, titled "Gesundheit braucht ...", puts patient care at the center. It names three priorities: giving policyholders orientation, developing care services further and strengthening prevention.

Mobil Krankenkasse leads the moVe-it consortium, which includes partners from science and healthcare delivery. The project aims to improve care for people with spasticity after a stroke through digital, interdisciplinary care management.

Sobi Raises 2026 Outlook as Q3 Revenue Climbs 16% to SEK 9.1B

STOCKHOLM – October 27, 2026 -- Sobi raised its 2026 revenue growth guidance to high-teens to low-20s per cent at constant exchange rates (CER), up from mid- to high-teens, after third-quarter revenue grew 16 per cent at CER to SEK 9,124 M (7,776). Reported growth was 17 per cent, and year-to-date growth stands at 23 per cent at CER. The company also announced that CEO Guido Oelkers will step down no later than the end of January 2027.

Haematology revenue rises 29% as Altuvoct sales more than double

Haematology revenue increased 29 per cent at CER to SEK 6,171 M (4,771). Altuvoct sales reached SEK 1,729 M, up from SEK 769 M a year earlier. Doptelet added SEK 1,829 M (1,408).

Revenue from Sobi's strategic portfolio grew 25 per cent at CER to SEK 6,298 M (5,001).

Alfa Laval Q3 Orders Surge 36% to SEK 23.2 Billion

LUND, Sweden – October 27, 2026 -- Alfa Laval's third-quarter order intake rose 36 percent to SEK 23.2 billion (17.1), with organic growth of 33 percent, while the company guided to somewhat lower demand in the fourth quarter.

Sales grow 8 percent as margin narrows to 18.1 percent

Net sales increased 8 percent to SEK 18,596 million (17,244), up 6 percent organically. Adjusted EBITA rose 6 percent to SEK 3,364 million (3,180). The adjusted EBITA margin slipped to 18.1 percent from 18.4 percent a year earlier.

Result after financial items reached SEK 3,050 million (2,967). Net income fell to SEK 2,262 million (2,303), and earnings per share declined to SEK 5.40 (5.53).

Operating cash flow climbs to SEK 3.4 billion

Cash flow from operating activities reached SEK 3,373 million, up from SEK 2,206 million in the prior-year quarter.

Flex LNG to Report Q2 2026 Results on August 19

Hamilton, Bermuda – October 27, 2026 -- Flex LNG Ltd will release unaudited second-quarter 2026 financial results on Wednesday, August 19, 2026, on or about 07:00 CEST (1:00 a.m. EST).

Flex LNG schedules live webcast for 15:00 CEST on results day

The company will hold a live video webcast at 15:00 CEST (9:00 a.m. EST) on the same day, eight hours after the release. Participants must register in advance, and Flex LNG advises doing so 5-10 minutes before the start.

Q&A session follows the presentation

A question-and-answer session will follow the presentation. Instructions for submitting questions will be given at the start of the webcast. Questions can also be sent in advance to the company's investor relations address.

Akari Q2 Net Loss Widens to $4.8M as AKTX-101 Nears IND

Tampa – October 27, 2026 -- Akari Therapeutics (Nasdaq: AKTX) reported a second-quarter 2026 net loss of $4.8 million, up from $1.9 million a year earlier, as research and development spending tripled to $2.1 million ahead of a planned Phase 1 start for its lead antibody drug conjugate (ADC), AKTX-101, in mid-2027.

Akari raised $8.6 million gross in the quarter, lifting cash to $7.7 million

The company closed a private placement with $5.5 million in gross proceeds and booked $3.1 million in gross proceeds from warrant exercises. Total gross financing was approximately $8.6 million, with approximately $8.0 million in net proceeds. Cash stood at $7.7 million on June 30, 2026, up from $5.2 million at December 31, 2025. Akari said long-term strategic investors led the financing.

Southwest Airlines Prices $1.25B Senior Notes Offering

Image
Southwest Airlines Prices $1.25B Senior Notes Offering

DALLAS – October 27, 2026 -- Southwest Airlines Co. (NYSE: LUV) priced an underwritten public offering of $1.25 billion in senior notes, split across two fixed-rate tranches maturing in 2029 and 2031.

Southwest splits the offering into $600 million at 5.750% and $650 million at 6.000%

The 2029 Notes total $600 million and carry a 5.750% rate. The 2031 Notes total $650 million and carry a 6.000% rate. The offering is expected to close on or about November 2, 2026, subject to customary closing conditions.

Proceeds may repay $300 million of 3.000% notes due November 15, 2026

Southwest plans to use net proceeds for general corporate purposes. These may include repaying at maturity all of its outstanding $300 million aggregate principal amount of 3.000% notes due November 15, 2026. Proceeds may also fund the repayment or redemption of other indebtedness or corporate obligations.

Energy Fuels Wins A$180M Conditional Backing for Donald Rare Earths

Image
Energy Fuels Wins A$180M Conditional Backing for Donald Rare Earths

DENVER – October 27, 2026 -- Export Finance Australia (EFA) and the National Reconstruction Fund Corporation (NRFC) have conditionally approved up to A$180 million (US$126 million) for Energy Fuels' Donald Rare Earth and Mineral Sands Project in Victoria, Australia. The commitment is part of a proposed A$200 million senior project finance debt facility for Phase 1 construction. Energy Fuels now targets a final investment decision (FID) by the end of 2026.

Government lenders cover A$180 million of the A$200 million debt package

The facility comprises up to A$70 million from EFA and up to A$110 million from NRFC. Commercial lenders are expected to provide the remaining A$20 million. The EFA and NRFC tranches carry a 10-year tenor from financial close, with interest priced at BBSY plus a margin.